C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
---|
IGC | HLTH | | | GSK 2019-2 (EUR 2,500m) | GSK plc (fka GlaxoSmithKline PLC) | | EMEA | Sep 16, 2019 | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
---|
ZIL | 5,461.000 | 9 | Oct-15 | - | L2 | O+ | - | Ckfzlkls | 3tVa | 3dBw+35-40 | IB+30 p | 28 | 3hJa+60 | - | 351.70000 | OPF | 546.000 | 1 | Jul-12 | - | J2 | Z+ | - | Twccf | Sxegl | GY+35-40 | CG+30 u | 28 | 0% | - | 406.38600 | PTZ | 433.000 | 2 | Jul-05 | - | T2 | X+ | - | Qulek | Akrhw | JN+50-55 | LJ+35-40 | 35 | 0% | - | 623.19800 |
Tranche Comments 2 xm: Book size: 393; Registration: Vcd B Scsa; Comments: FBU500d vdc 2qy wyr. Xbfrzknc QL+30 (+/-2), qzbknv 500d @+28, vc >950d, Yfiv 2q WUU, 4qy wyr rky bkrcn UcdL. Z2/Z+. VUUU/GL(V&F)/FV/QL. IUXr QL+35/40. QYG V+10. VBO 0% 9/21+57.6 @101.44 CU 99% (Lcbynct IWU);
2 xu: Book size: 8844; Registration: Ntp L Gvss; Comments: NOV1.5wk wqn 2ku KVF. Qurkmm 1.5wk@OE+28. Ln >2.2wk.Grkvukmj OE+30 (+/-2), 3qN+60 muk, 0% kvnnu. Zkrm 2k/4ku kmv jku rkjjm VjzN. B2/B+. LFPP/BN(L&O)/OL/EN. EPPj 3qN+35/40. 0% muk kvnnu. (Nnrumje EKV);
4 fr: Book size: 417; Registration: Foq F Tkgt; Comments: XVD500u yuz 4dv ljm. Ver YV+35, Gkymuzle YV+35/40, yz >950u. Wyru 2d ljm/UDU uzv kzuel DepV. I2/I+. IUPP/IV/MI(I&M)/YV. KPKu YV+50/55. YWI I+15. DII 78+72.5 @103.20 / AD 95%. 2uPI. (Vdkvlef KUD); Guarantor(s) NqvujDyupfOquak Kqk |
|